Water

Water

SCHEMBL8098375

Cl[Zn].Cl[Zn].O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL1505724 1.00
Water SCHEMBL9279773 1.00
Water SCHEMBL3477607 1.00
Hydrochloric Acid SCHEMBL7109535 0.89
Hydrochloric Acid SCHEMBL6130328 0.89
Water SCHEMBL27382625 0.89
SCHEMBL412138 0.87
Magnesium Chloride Anhydrous SCHEMBL27658389 0.76
Methane SCHEMBL1149323 0.75
SCHEMBL4651045 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109503619-A A kind of synthetic method of D-biotin 浙江新和成股份有限公司 2019-03-22 CN claimed
CN-109503620-A The preparation method of 5- (2- oxo thiophane and imidazoles -4 (2H)-alkenyl) penta acid compounds 浙江新和成股份有限公司 2019-03-22 CN claimed
WO-2024120424-A1 COMPOUND TARGETING PAN-KRAS PROTEIN DEGRADATION AGENT AND USE THEREOF 贝达药业股份有限公司 2024-06-13 WO disclosed
WO-2023193795-A1 COMPOUND TARGETING FOCAL ADHESION KINASE AND PREPARATION METHOD FOR AND APPLICATION OF COMPOUND 北京师范大学 2023-10-12 WO disclosed
WO-2023138524-A1 KRAS G12D DEGRADATION AGENT AND MEDICAL USE THEREOF 贝达药业股份有限公司 2023-07-27 WO disclosed
WO-2020147848-A1 TRICYCLIC SUBSTITUTED OXASPIRO DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 上海海雁医药科技有限公司 2020-07-23 WO disclosed
CN-109503619-A A kind of synthetic method of D-biotin 浙江新和成股份有限公司 2019-03-22 CN disclosed
CN-109503620-A The preparation method of 5- (2- oxo thiophane and imidazoles -4 (2H)-alkenyl) penta acid compounds 浙江新和成股份有限公司 2019-03-22 CN disclosed
CN-1300279-A Modulators of protein tyrosine phosphatases NOVO NORDISK AS (DK) 2001-06-20 CN disclosed
CN-1300291-A Modulators of protein tyrosine phosphatases (PTP enzymes) NOVO NORDISK AS (DK) 2001-06-20 CN disclosed
US-6090804-A PSYCHOLOGICAL DISORDERS; SCHIZOPHRENIA THERAPY YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2000-07-18 US disclosed
US-6034280-A Process for the production of 2,5-dimethyl-2,5-di-t-butylperoxy-hexane PEROXID-CHEMIE GMBH (DE) 2000-03-07 US disclosed
CN-1233176-A Substituted tricyclics LILLY CO ELI (US) 1999-10-27 CN disclosed